Literature DB >> 20620599

Relevance of miR-21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases.

Vlastimil Kulda1, Martin Pesta, Ondrej Topolcan, Vaclav Liska, Vladislav Treska, Alan Sutnar, Karel Rupert, Marie Ludvikova, Vaclav Babuska, Lubos Holubec, Radim Cerny.   

Abstract

MicroRNAs, which are endogenously expressed regulatory noncoding RNAs, have an altered expression in colorectal cancer. The aim of our study was to assess the relationship of miR-21 and miR-143 expression to the prognostic/clinicopathological features of colorectal carcinoma (CRC) and colorectal liver metastases (CLM). The estimation was performed in 46 paired (tumor and control) tissue samples of CRC. Further, we studied 30 tissue samples of CLM. MiR-21 and miR-143 expressions were quantified by using the quantitative reverse transcription polymerase chain reaction method. Relation of miR-21 and miR-143 expression to disease-free interval (DFI) (Wilcoxon; P = 0.0026 and P = 0.0191, respectively) was recorded. There was shorter DFI in patients with a higher expression of miR-21 and, surprisingly, also in patients with a higher expression of miR-143, which is a putative tumor suppressor. There was a higher expression of miR-21 and lower expression of miR-143 in CRC tissue in comparison with adjacent normal colon tissue (P < 0.0001; P < 0.0001, respectively). Similarly, we observed a higher expression of miR-21 and a lower expression of miR-143 in CLM in comparison with normal colon tissue (P < 0.0001; P < 0.0001, respectively). Our results support the hypothesis about oncogenic function of miR-21 and show its relation to DFI. The role of miR-143 in carcinogenesis seems to be more complex. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20620599     DOI: 10.1016/j.cancergencyto.2010.04.015

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  67 in total

1.  Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; Nadarajah Vigneswaran; John R Klein
Journal:  J Immunol       Date:  2011-10-31       Impact factor: 5.422

Review 2.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

3.  MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma.

Authors:  Andrew Feber; Liqiang Xi; Arjun Pennathur; William E Gooding; Santhoshi Bandla; Maoxin Wu; James D Luketich; Tony E Godfrey; Virginia R Litle
Journal:  Ann Thorac Surg       Date:  2011-03-21       Impact factor: 4.330

4.  Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.

Authors:  Keun Hur; Yuji Toiyama; Aaron J Schetter; Yoshinaga Okugawa; Curtis C Harris; C Richard Boland; Ajay Goel
Journal:  J Natl Cancer Inst       Date:  2015-02-06       Impact factor: 13.506

5.  High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer.

Authors:  Naohide Oue; Katsuhiro Anami; Aaron J Schetter; Markus Moehler; Hirokazu Okayama; Mohammed A Khan; Elise D Bowman; Annett Mueller; Arno Schad; Manabu Shimomura; Takao Hinoi; Kazuhiko Aoyagi; Hiroki Sasaki; Masazumi Okajima; Hideki Ohdan; Peter R Galle; Wataru Yasui; Curtis C Harris
Journal:  Int J Cancer       Date:  2013-11-08       Impact factor: 7.396

Review 6.  miRNAs derived from cancer-associated fibroblasts in colorectal cancer.

Authors:  Amir Savardashtaki; Zahra Shabaninejad; Ahmad Movahedpour; Roxana Sahebnasagh; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2019-11-08       Impact factor: 4.778

7.  MicroRNAs and their role for T stage determination and lymph node metastasis in early colon carcinoma.

Authors:  Melanie Rammer; Gerald Webersinke; Sophie Haitchi-Petnehazy; Eva Maier; Hubert Hackl; Pornpimol Charoentong; Theodora Malli; Maria Steinmair; Andreas L Petzer; Holger Rumpold
Journal:  Clin Exp Metastasis       Date:  2017-11-13       Impact factor: 5.150

8.  Interaction of the oncogenic miR-21 microRNA and the p53 tumor suppressor pathway.

Authors:  Xiaodong Ma; Saibyasachi N Choudhury; Xiang Hua; Zhongping Dai; Yong Li
Journal:  Carcinogenesis       Date:  2013-02-05       Impact factor: 4.944

Review 9.  MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.

Authors:  Shan Muhammad; Kavanjit Kaur; Rui Huang; Qian Zhang; Paviter Kaur; Hamza Obaid Yazdani; Muhammad Umar Bilal; Jiang Zheng; Liu Zheng; Xi-Shan Wang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer.

Authors:  Yuji Toiyama; Masanobu Takahashi; Keun Hur; Takeshi Nagasaka; Koji Tanaka; Yasuhiro Inoue; Masato Kusunoki; C Richard Boland; Ajay Goel
Journal:  J Natl Cancer Inst       Date:  2013-05-23       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.